Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
The age-related macular degeneration (AMD) field is witnessing promising advancements in therapeutic options. Breakthrough drugs such as pegcetacoplan and avacincaptad have been FDA-approved for dry AMD, marking a significant development as there were no treatment options until August 2023. While se...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| シリーズ: | Indian Journal of Ophthalmology |
| 主題: | |
| オンライン･アクセス: | https://journals.lww.com/10.4103/IJO.IJO_1120_24 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|